查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1458769

2024 年全基因组和EXOME定序全球市场报告

Whole Genome And Exome Sequencing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

全基因组和EXOME定序市场规模预计在未来几年将呈指数级增长。 2028年，将以24.8%的复合年增长率成长至49.1亿美元。预测期内的预期增长将受到人口基因组学的努力、精准医疗需求的增加、单细胞定序的进步、非侵入性产前检测（NIPT）的扩展以及罕见疾病研究的应用的推动。预计这段时期的主要趋势包括临床应用的增加、定序技术的快速进步、群体规模基因组研究的兴起以及人工智慧（AI）和机器学习（ML）在肿瘤学中的整合，其中包括扩大肿瘤学的应用。

人们对个人化医疗的兴趣日益浓厚，预计将在未来几年推动全基因组和EXOME定序市场的扩张。个人化医疗采用量身定制的医疗保健方法，在做出治疗决定时考虑到患者的个别特征，例如遗传、环境和生活方式。全基因组和EXOME定序透过全面分析个体的基因组成并针对特定的遗传、环境和生活方式因素进行客製化医疗干预来实现个体化，它在医学中发挥着至关重要的作用。例如，截至2022年10月，个人化医疗联盟（PMC）预测，市场上将有超过75,000种基因检测产品和超过300种个人化药物。此外，美国食品药物管理局（FDA）药物评估与研究中心（CDER）将于2022年核准37个新分子实体（NME），这35个治疗性NME中约34%将被归类为个人化医疗。因此，对个人化医疗不断增长的需求正在推动全基因组和EXOME定序市场的扩张。

全基因组和EXOME定序市场的主要企业正在加紧努力，开拓最尖端科技解决方案，特别是超快速NGS（次世代定序仪）分析，以获得竞争优势。这项创新有助于快速处理 NGS资料并大幅缩短分析时间。例如，美国生物资讯公司 QIAGEN Digital Insights (QDI) 于 2023 年 1 月宣布推出超快速 NGS 分析平台。该平台提高了效率、经济性和扩充性，拥有诸如只需 25 分钟即可处理整个基因组、云端运算成本为 1 美元等功能。这项技术突破大大提高了基因组资料分析的速度和可近性，透过实现快速决策和个人化医疗的普及，在全基因组和EXOME定序市场中发挥关键作用。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球全基因组和EXOME定序市场，依产品类型、表现和预测细分，2018-2023、2023-2028、2033
  • 套件
  • 装置
  • 全球全基因组和EXOME定序市场，依工作流程、绩效和预测细分，2018-2023、2023-2028、2033
  • 全基因组定序（WGS）
  • 全EXOME定序（WES）
  • 全球全基因组和EXOME定序市场，按应用细分、实际和预测，2018-2023、2023-2028、2033
  • 诊断
  • 癌症
  • 单基因疾病
  • 糖尿病
  • 药物发现与开发
  • 个人化医疗
  • 农业和动物研究
  • 其他应用
  • 全球全基因组和EXOME定序市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 研究中心
  • 学术和政府机构
  • 医院和诊所
  • 製药和生物技术公司
  • 其他最终用户

第 7 章 区域/国家分析

  • 全球全基因组和EXOME定序市场，按地区、实际和预测，2018-2023、2023-2028、2033
  • 全球全基因组和EXOME定序市场，按国家、实际和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 全基因组与EXOME定序市场竞争格局
  • 全基因组和EXOME定序市场公司概况
    • Siemens AG
    • Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Cytiva（Danaher Corporation）
    • Laboratory Corporation of America Holdings（Labcorp）

第31章 其他大型创新企业

  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Canon Medical Systems Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Neusoft Corporation
  • BGI Genomics
  • Mirion Technologies（Capintec）Inc.
  • Novogene Co.
  • Oxford Nanopore Technologies Inc.
  • LANDAUER
  • Pacific Biosciences of California Inc.
  • Digirad Corporation
  • Berthold Technologies GmbH &Co.KG

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r16751

Whole genome sequencing (WGS) and exome sequencing (ES) are advanced genetic analysis methodologies aimed at deciphering an organism's complete DNA sequence and specifically targeting the protein-coding regions of the genome. These techniques play a crucial role in diagnosing genetic disorders and identifying cancer-related mutations.

The primary product categories in WGS and ES comprise kits and instruments, where kits encompass a collection of related products packaged together for simplified inventory management. Various workflows such as whole genome sequencing (WGS) and whole exome sequencing (WES) are utilized across multiple applications including diagnostics, cancer research, monogenic disorders, drug development, personalized medicine, agriculture, and animal research. End users encompass diverse entities such as research centers, academic institutions, governmental bodies, hospitals, pharmaceutical and biotechnology companies, among others.

The whole genome and exome sequencing market research report is one of a series of new reports from The Business Research Company that provides whole genome and exome sequencing market statistics, including whole genome and exome sequencing industry global market size, regional shares, competitors with a whole genome and exome sequencing market share, detailed whole genome and exome sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the whole genome and exome sequencing industry. This whole genome and exome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The whole genome and exome sequencing market size has grown exponentially in recent years. It will grow from $1.61 billion in 2023 to $2.02 billion in 2024 at a compound annual growth rate (CAGR) of 25.5%. The growth observed during the historical period can be ascribed to declining sequencing costs, an increase in genetic disorders, clinical applications, the establishment of genomic data repositories, and advancements in bioinformatics.

The whole genome and exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $4.91 billion in 2028 at a compound annual growth rate (CAGR) of 24.8%. The anticipated growth in the forecast period is driven by population genomics initiatives, increased demand for precision medicine, advancements in single-cell sequencing, expansion of non-invasive prenatal testing (NIPT), and its application in rare disease research. Key trends expected during this period include increased clinical adoption, rapid advancements in sequencing technologies, the rise of population-scale genomic studies, integration of artificial intelligence (AI) and machine learning (ML), and expanding applications in oncology.

The increasing interest in personalized medicine is anticipated to drive the expansion of the whole genome and exome sequencing market in the coming years. Personalized medicine adopts a tailored approach to healthcare, considering individual patient characteristics such as genetics, environment, and lifestyle in treatment decisions. Whole genome and exome sequencing play a pivotal role in personalized medicine by offering a comprehensive analysis of an individual's genetic composition, enabling healthcare interventions customized to their specific genetic, environmental, and lifestyle factors. For example, as of October 2022, the Personalized Medicine Coalition (PMC) projects over 75,000 genetic testing products and 300 personalized medicines to be available on the market. Additionally, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022, with approximately 34% classified as personalized among the 35 therapeutic NMEs. Consequently, the growing demand for personalized medicine is fueling the expansion of the whole genome and exome sequencing market.

Major players in the whole genome and exome sequencing markets are intensifying their efforts towards developing cutting-edge technological solutions, notably ultra-fast NGS (next-generation sequencing) analysis, to gain a competitive advantage. This innovation facilitates the rapid processing of NGS data, drastically reducing analysis time. For example, in January 2023, QIAGEN Digital Insights (QDI), a US-based bioinformatics company, introduced an ultra-fast NGS analysis platform. This platform boasts features such as processing a whole genome in just 25 minutes at a cost of $1 in cloud computing expenses, promoting efficiency, affordability, and scalability. Its technological breakthrough significantly enhances the speed and accessibility of genomic data analysis, playing a crucial role in the whole genome and exome sequencing market by enabling swift decision-making and wider adoption of personalized medicine.

In January 2023, QIAGEN, a multinational corporation headquartered in Germany and specializing in sample technologies and molecular insights products, acquired Verogen for an undisclosed sum. This acquisition bolsters QIAGEN's presence in the human identification and forensics market, consolidating its leadership position and facilitating the creation of more comprehensive solutions with potential implications for the entire genome and exome sequencing market. Verogen, based in the United States, is a biotech company that offers next-generation sequencing (NGS) tools and services, including whole genome and exome sequencing.

Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan.

North America was the largest region in the whole genome and exome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the whole genome and exome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The whole genome and exome sequencing market consists of revenues earned by entities by providing services such as genetic profiling, variant identification, personalized medicine solutions, and comprehensive genomic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The whole genome and exome sequencing market also includes sales of exome capture kits, benchtop sequencer, and sample preparation instrutments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Whole Genome And Exome Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on whole genome and exome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for whole genome and exome sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The whole genome and exome sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Kits; Instruments
  • 2) By Workflow: Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES)
  • 3) By Applications: Diagnostics; Cancer; Monogenic Disorders; Diabetes; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research; Other Applications
  • 4) By End user: Research Center; Academic And Government Institutions; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
  • Companies Mentioned: Siemens AG; Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Cytiva (Danaher Corporation); Laboratory Corporation of America Holdings (Labcorp)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Whole Genome And Exome Sequencing Market Characteristics

3. Whole Genome And Exome Sequencing Market Trends And Strategies

4. Whole Genome And Exome Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Whole Genome And Exome Sequencing Market Size and Growth

  • 5.1. Global Whole Genome And Exome Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Whole Genome And Exome Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Whole Genome And Exome Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Whole Genome And Exome Sequencing Market Segmentation

  • 6.1. Global Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Kits
  • Instruments
  • 6.2. Global Whole Genome And Exome Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • 6.3. Global Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Cancer
  • Monogenic Disorders
  • Diabetes
  • Drug Discovery And Development
  • Personalized Medicine
  • Agriculture And Animal Research
  • Other Applications
  • 6.4. Global Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research Center
  • Academic And Government Institutions
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End Users

7. Whole Genome And Exome Sequencing Market Regional And Country Analysis

  • 7.1. Global Whole Genome And Exome Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Whole Genome And Exome Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Whole Genome And Exome Sequencing Market

  • 8.1. Asia-Pacific Whole Genome And Exome Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Whole Genome And Exome Sequencing Market

  • 9.1. China Whole Genome And Exome Sequencing Market Overview
  • 9.2. China Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Whole Genome And Exome Sequencing Market

  • 10.1. India Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Whole Genome And Exome Sequencing Market

  • 11.1. Japan Whole Genome And Exome Sequencing Market Overview
  • 11.2. Japan Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Whole Genome And Exome Sequencing Market

  • 12.1. Australia Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Whole Genome And Exome Sequencing Market

  • 13.1. Indonesia Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Whole Genome And Exome Sequencing Market

  • 14.1. South Korea Whole Genome And Exome Sequencing Market Overview
  • 14.2. South Korea Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Whole Genome And Exome Sequencing Market

  • 15.1. Western Europe Whole Genome And Exome Sequencing Market Overview
  • 15.2. Western Europe Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Whole Genome And Exome Sequencing Market

  • 16.1. UK Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Whole Genome And Exome Sequencing Market

  • 17.1. Germany Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Whole Genome And Exome Sequencing Market

  • 18.1. France Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Whole Genome And Exome Sequencing Market

  • 19.1. Italy Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Whole Genome And Exome Sequencing Market

  • 20.1. Spain Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Whole Genome And Exome Sequencing Market

  • 21.1. Eastern Europe Whole Genome And Exome Sequencing Market Overview
  • 21.2. Eastern Europe Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Whole Genome And Exome Sequencing Market

  • 22.1. Russia Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Whole Genome And Exome Sequencing Market

  • 23.1. North America Whole Genome And Exome Sequencing Market Overview
  • 23.2. North America Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Whole Genome And Exome Sequencing Market

  • 24.1. USA Whole Genome And Exome Sequencing Market Overview
  • 24.2. USA Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Whole Genome And Exome Sequencing Market

  • 25.1. Canada Whole Genome And Exome Sequencing Market Overview
  • 25.2. Canada Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Whole Genome And Exome Sequencing Market

  • 26.1. South America Whole Genome And Exome Sequencing Market Overview
  • 26.2. South America Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Whole Genome And Exome Sequencing Market

  • 27.1. Brazil Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Whole Genome And Exome Sequencing Market

  • 28.1. Middle East Whole Genome And Exome Sequencing Market Overview
  • 28.2. Middle East Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Whole Genome And Exome Sequencing Market

  • 29.1. Africa Whole Genome And Exome Sequencing Market Overview
  • 29.2. Africa Whole Genome And Exome Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Whole Genome And Exome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Whole Genome And Exome Sequencing Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Whole Genome And Exome Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Whole Genome And Exome Sequencing Market Competitive Landscape
  • 30.2. Whole Genome And Exome Sequencing Market Company Profiles
    • 30.2.1. Siemens AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Cytiva (Danaher Corporation)
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings (Labcorp)
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Whole Genome And Exome Sequencing Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific SE
  • 31.2. Agilent Technologies Inc.
  • 31.3. Illumina Inc.
  • 31.4. Canon Medical Systems Corporation
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. QIAGEN N.V
  • 31.7. Neusoft Corporation
  • 31.8. BGI Genomics
  • 31.9. Mirion Technologies (Capintec) Inc.
  • 31.10. Novogene Co.
  • 31.11. Oxford Nanopore Technologies Inc.
  • 31.12. LANDAUER
  • 31.13. Pacific Biosciences of California Inc.
  • 31.14. Digirad Corporation
  • 31.15. Berthold Technologies GmbH & Co.KG

32. Global Whole Genome And Exome Sequencing Market Competitive Benchmarking

33. Global Whole Genome And Exome Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Whole Genome And Exome Sequencing Market

35. Whole Genome And Exome Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Whole Genome And Exome Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Whole Genome And Exome Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Whole Genome And Exome Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer